This review explored the potential use of VWF as a biomarker for valvular heart disease in addition to exploring its use in providing real-time feedback to detect paravalvular regurgitation during the TAVR procedure. This review concluded that larger-scale studies would be required to fill existing knowledge gaps prior to widescale implementation. Here, VWF is linked to heart valve disorder.